Loay Mahmoud

Norwegian University of Science and Technology — Norway

Medicine · Health Sciences

5h-index79citations16works3.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(9), Protein Degradation and Inhibitors(5), Peptidase Inhibition and Analysis(4), Cancer Genomics and Diagnostics(3), CAR-T cell therapy research(3)

Publications16 total

CDK2 inhibition promotes neuronal differentiation in neuroblastoma
Scientific Reports·2026Open Access
Diffusion Smart-seq3 of breast cancer spheroids to explore spatial tumor biology and test evolutionary principles of tumor heterogeneity
Scientific Reports·2025· 11 citedOpen Access
Diffusion Smart-seq3 of breast cancer spheroids to explore spatial tumor biology and test evolutionary principles of tumor heterogeneity
2024Open Access
MYCN Amplification Is Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in Neuroblastoma
International Journal of Molecular Sciences·2023· 10 citedOpen Access
Data from MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding
2023Open Access
Supplementary Materials and Methods, Figures 1-6 from MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner
2023Open Access
Data from MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner
2023Open Access
Supplementary Data from MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding
2023Open Access
Data from MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding
2023Open Access
Supplementary Data from MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding
2023Open Access
Data from MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner
2023Open Access
Supplementary Materials and Methods, Figures 1-6 from MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner
2023Open Access
Microscopy-based phenotypic monitoring of MDA-MB-231 spheroids allows the evaluation of phenotype-directed therapy
Experimental Cell Research·2023· 10 citedOpen Access
Breast cancer spheroids can model phenotypic heterogeneity of cancer cells to evaluate targeted therapies.
Research Square (Research Square)·2022Open Access
MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner
Cancer Research Communications·2022· 17 citedOpen Access
MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding
Cancer Research Communications·2022· 31 citedOpen Access

Frequent Co-authors

Mohammad Alzrigat(12), Lars‐Gunnar Larsson(11), Wesam Bazzar(7), Daniel Massó-Vallés(5), Marie-Ève Beaulieu(5), Toni Jauset(5), Fabio Giuntini(5), Mariano F. Zacarías Fluck(5), Laia Foradada(5), Sandra Martínez-Martín(5), Erika Serrano(5), Génesis Martín-Fernández(5), Sílvia Casacuberta‐Serra(5), Virginia Castillo Cano(5), Jastrinjan Kaur(5), Sergio López‐Estévez(5), Miguel A. Morcillo(5), Antonio Luque-García(5), Marta Escorihuela(5), Marta Guzmán(5)